A Utah program provides comprehensive care for autistic people across the lifespan and engages families in the decision-making.

An experimental drug that muffles the activity of neurons in the skin moderates heightened reactions to touch in six mouse models of autism.

An experimental behavioral therapy delivered by parents does not improve autism traits in babies who screen positive for the condition.

The more words autistic children hear as infants — and the more verbal interactions they have with their caregivers — the better their language skills at age 2.

Autistic people are four times as likely to experience depression over the course of their lives as their neurotypical peers. Yet researchers know little about why, or how best to help.

Results from a new trial suggest that it’s safe to treat autistic children with umbilical cord stem cells. But parents must pay for the pricey infusions, and no one knows how or if the cells work.

Most community clinicians do not deliver care that is in line with the latest evidence — and they are not improving over time.

At 10 months of age, infants later diagnosed with autism show key differences in joint attention, a behavior in which two people focus on the same object or event.

Families of children with mutations in a gene called SYNGAP1 have spurred research into the effects of the mutations on people — and how to treat them.

A drug that mimics the hormone vasopressin improves social skills in autistic people — but so does one that blocks vasopressin’s effects. How can seemingly opposing manipulations produce similar results?